Infectious Disease Treatment Market in China to grow at a CAGR of 5.01% during the period 2016 - 2020; Finds New Report

Report forecast the infectious disease treatment market in China to grow at a CAGR of 5.01% during the period 2016-2020.

Infectious diseases are caused by pathogenic microorganisms such as bacteria, parasites, fungi, or viruses. They can be transmitted from one person to another through direct or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on target organism, anti-infective drugs can be categorized into antibacterial, antifungal, antiviral, and antiparasitic.

The report covers the present scenario and the growth prospects of the infectious disease treatment market in China for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat infectious diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

According to the report, a key growth driver is the use of combination therapies. Physicians are increasingly prescribing drugs that are a combination of an anti-infective and a corticosteroid. Anti-infectives help reduce infection while corticosteroids reduce the inflammation. Anti-infectives, when used alone, also take a longer time for disease remission. Some examples of combination drugs used to treat conjunctivitis include Neo-Poly-Dex eye drops by Bausch & Lomb and Maxitrol by Alcon, which contain polymyxin B sulfates and neomycin and dexamethasone.

Further, the report states that one challenge that could hamper market growth is the development of drug resistant strains of microbes.

Infectious Disease Treatment Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the infectious disease treatment market in China: F. Hoffmann-La Roche, Gilead Sciences, GSK, Johnson & Johnson, Merck, and Pfizer.

Other Prominent Vendors in the market are: Achaogen, Actelion, Adenovir Pharma, AstraZeneca, Bayer, Biocryst, Celsus therapeutics, Cempra, Eleven Biotherapeutics, Exoxemis, Ferrer International, Griffin Discoveries, Hexima, InSite Vision, Insmed Incorporated, KaloBios Pharmaceuticals, Lytix Biopharma, Meiji Seika Pharma, Melinta Therapeutics, Moberg Pharma, NanoViricides, Nektar, NicOx, NovaBay, NovaBiotics, Ocular Therapeutix, Panoptes Pharma, Paratek Pharmaceuticals, Polichem, PTC Therapeutics, RedHill, Shire, Starpharma Holding, Sun Pharma, Symbiomix, Tetraphase Pharmaceuticals, The Medicines Company, Theravance Biopharma, Theravance Biopharma, Topica Pharmaceuticals, Vertex Pharmaceuticals, and Viamet Pharmaceuticals.

Market driver

• Use of combination therapies
• For a full, detailed list, view our report

Market challenge

• Development of drug resistant strains
• For a full, detailed list, view our report

Market trend

• Emergence of interferon (IFN)-free therapies
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 125 pages and 70 Exhibit “Infectious Disease Treatment Market in China 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, China - An overview, Opportunities for global and local vendors, Pipeline analysis, Market landscape, Market segmentation by application, Antibacterial drugs market in China, Antiviral drugs market in China, Antifungal drugs market in China, Antiparasitic drugs market in China, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://mrr.cm/JnM

Related Report;

Global Sports Medicine Market 2016-2020 - Visit at - http://mrr.cm/JnQ